Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment‐related aspects of apathy from depression in neurocognitive disorders
Различение апатии и депрессии: обзор, посвящённый различиям между апатией и депрессией в поведенческих, нейроанатомических и связанных с лечением аспектах при нейрокогнитивных расстройствах
2023-01-23
SCID: 54.1/7dkj6rbp
Discuss with AI
Alzheimer's diseaseapathydepressionneurocognitive disordersneuropsychiatric syndromes
Figures from the paper
Abstract (AI)
OBJECTIVES: This narrative review describes the clinical features of apathy and depression in individuals with neurocognitive disorders (NCDs), with the goal of differentiating the two syndromes on the basis of clinical presentation, diagnostic criteria, neuropathological features, and contrasting responses to treatments. METHODS: Literature was identified using PubMed, with search terms to capture medical conditions of interest; additional references were also included based on our collective experience and knowledge of the literature. RESULTS: Evidence from current literature supports the distinction between the two disorders; apathy and depression occur with varying prevalence in individuals with NCDs, pose different risks of progression to dementia, and have distinct, if overlapping, neurobiological underpinnings. Although apathy is a distinct neuropsychiatric syndrome, distinguishing apathy from depression can be challenging, as both conditions may occur concurrently and share several overlapping features. Apathy is associated with unfavorable outcomes, especially those with neurodegenerative etiologies (e.g., Alzheimer's disease) and is associated with an increased burden for both patients and caregivers. Diagnosing apathy is important not only to serve as the basis for appropriate treatment, but also for the development of novel targeted interventions for this condition. Although there are currently no approved pharmacologic treatments for apathy, the research described in this review supports apathy as a distinct neuropsychiatric condition that warrants specific treatments aimed at alleviating patient disability. CONCLUSIONS: Despite differences between these disorders, both apathy and depression pose significant challenges to patients, their families, and caregivers; better diagnostics are needed to develop more tailored treatment and support.
Key Findings
1
Apathy and depression differ in clinical presentation, diagnostic criteria, prevalence, risks of dementia progression, neurobiological underpinnings, and treatment responses.
2
Apathy can be difficult to distinguish from depression because the conditions may co-occur and share several clinical features.
3
Apathy is particularly associated with unfavorable outcomes in neurodegenerative disorders such as Alzheimer’s disease and increases burden for patients and caregivers.
4
No pharmacologic treatments for apathy are currently approved, highlighting the need for targeted therapies and improved diagnostic approaches.
5
The review supports apathy and depression as distinct, though overlapping, neuropsychiatric syndromes in individuals with neurocognitive disorders.
Research Object
Apathy and depression in individuals with neurocognitive disorders
Research Subject
The behavioral, neuroanatomic, neuropathological, diagnostic, and treatment-response differences and overlaps between apathy and depression
Publication Details
Publication Date
2023-01-23
Journal
Publisher
ISSN
Cited by
91
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest